Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHays Regulatory News (HAS)

Share Price Information for Hays (HAS)

Share Price is delayed by 15 minutes
Get Live Data
33.84    -0.40 (-1.17%)
Bid:
34.00
Ask:
34.72
Spread: 0.72 (2.118%)
Market Cap: £541.11m
HAS Live PriceLast checked at - London Stock Exchange

Intraday Hays Share Chart

Board Changes

16 Jan 2025 07:00

RNS Number : 4829T
Hays PLC
16 January 2025
 

16 January 2025

 

HAYS PLC

BOARD CHANGES

Hays plc ("Hays") today announces the appointment of Michael Findlay to its Board as a Non-Executive Director and Chair-designate. He will join the Board on 20 January 2025 and will succeed Andrew Martin as Non-Executive Chair from 1 May 2025. Andrew will retire on 1 May 2025 after nearly 8 years on the Board.

Michael Findlay is currently Non-Executive Chair of London Stock Exchange plc and a Non-Executive Director of International Distribution Services plc and Jarrold & Sons Limited. Michael is also Chair of Morgan Sindall Group plc but announced yesterday that he will be stepping down from the Board on 28 July 2025. Previous roles include co-head of investment banking for UK and Ireland at Bank of America and Senior Independent Director at UK Mail Group plc.

Cheryl Millington, Hays' Senior Independent Director, who led the succession process, said: "I am delighted that Michael will be joining the Hays Board. Michael is a highly accomplished business leader and a proven Non-Executive and Chair. Having spent his executive career in corporate broking and investment banking, Michael has advised many leading UK plcs on a wide range of strategic, financing and governance matters. He also brings a strong understanding of people intensive and service orientated businesses."

"I also want to take this opportunity to thank Andy on behalf of the Board for his exemplary leadership, during a period of significant change for the Group, and wish him all the very best for the future."

Michael said: "I am delighted to be joining Hays and I look forward to working with the Board and the executive team to drive forward the Group's strategy to create significant value for all stakeholders."

Andy Martin commented: "It has been a privilege to serve on the Board of Hays for nearly 8 years. It is a great company and I wish all of the incredible team every success for the future, and wish Michael all the very best as he leads the Board on this next important step of the Hays journey."

This announcement is made in accordance with Listing Rule 6.4.6. There are no further matters to be disclosed under Listing Rule 6.4.8.

 

Enquiries

Hays plc

Rachel FordKean Marden

FGS GlobalGuy Lamming / Anjali Unnikrishnan / Richard Crowley

 

General Counsel & Company Secretary

Head of Investor Relations & ESG

 

+44 (0) 333 010 2682

+44 (0) 333 010 7092hays@fgsglobal.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUVANRVAUAAAR
Date   Source Headline
25th Sep 20253:54 pmRNSDirector/PDMR Shareholding
18th Sep 20251:29 pmRNSDirector/PDMR Shareholding
15th Sep 20254:50 pmRNSDirector/PDMR Shareholding
5th Sep 20252:52 pmRNSDirector/PDMR Shareholding
3rd Sep 20253:00 pmRNSDirector/PDMR Shareholding
1st Sep 202510:00 amRNSTotal Voting Rights
29th Aug 202512:59 pmRNSDirector/PDMR Shareholding
27th Aug 202512:32 pmRNSDirector/PDMR Shareholding
26th Aug 20253:43 pmRNSDirector/PDMR Shareholding
22nd Aug 20253:00 pmRNSDirector/PDMR Shareholding
21st Aug 20254:30 pmRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSPreliminary Report 2025
4th Aug 20254:21 pmRNSTotal Voting Rights
1st Aug 202510:00 amRNSBlock listing Interim Review
23rd Jul 202510:38 amRNSHolding(s) in Company
14th Jul 20255:19 pmRNSHolding(s) in Company
11th Jul 20251:00 pmRNSAppointment of Joint Corporate Broker
4th Jul 20252:43 pmRNSBoard Committee membership changes
1st Jul 202510:00 amRNSTotal Voting Rights
24th Jun 20257:00 amRNSHolding(s) in Company
20th Jun 20259:37 amRNSDirector/PDMR Shareholding
19th Jun 202510:18 amRNSHolding(s) in Company
19th Jun 20257:00 amRNSPre-Close Year End Trading Update
4th Jun 20251:40 pmRNSHolding(s) in Company
3rd Jun 20255:54 pmRNSDirector/PDMR Shareholding
2nd Jun 202510:00 amRNSTotal Voting Rights
29th May 20253:46 pmRNSHolding(s) in Company
20th May 20254:55 pmRNSResponse to Voting Results at 2024 AGM
9th May 20252:24 pmRNSOutcome of Audit Tender Process
1st May 202510:00 amRNSTotal Voting Rights
16th Apr 20254:22 pmRNSDirector/PDMR Shareholding
16th Apr 20257:00 amRNSThird Quarter Trading Statement
15th Apr 20255:15 pmRNSDirector/PDMR Shareholding
10th Apr 20254:10 pmRNSDirector/PDMR Shareholding
1st Apr 202510:00 amRNSTotal Voting Rights
27th Mar 202512:05 pmRNSDirector/PDMR Shareholding
3rd Mar 202510:00 amRNSTotal Voting Rights
25th Feb 20252:30 pmRNSDirector/PDMR Shareholding
20th Feb 20257:00 amRNSHalf Year Report
3rd Feb 202510:15 amRNSBlock listing Interim Review
3rd Feb 202510:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSBoard Changes
15th Jan 20257:00 amRNSSecond Quarter Trading Statement
13th Jan 20252:14 pmRNSDirector Declaration
2nd Jan 202510:50 amRNSHolding(s) in Company
2nd Jan 202510:35 amRNSTotal Voting Rights
17th Dec 20241:00 pmRNSDirector/PDMR Shareholding
16th Dec 20249:17 amRNSDirector/PDMR Shareholding
9th Dec 20242:37 pmRNSDB pension scheme de-risked with full buy-in
2nd Dec 202411:55 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.